{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:18:43Z","timestamp":1792603123896,"version":"4.5.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2020,9,1]]},"DOI":"10.1001\/jamaophthalmol.2020.2443","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T13:46:03Z","timestamp":1594907163000},"page":"935","source":"Crossref","is-referenced-by-count":163,"title":["Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy"],"prefix":"10.1001","volume":"138","author":[{"given":"Tock H.","family":"Lim","sequence":"first","affiliation":[{"name":"National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore"},{"name":"Fundus Image Reading Centre, National Healthcare Group Eye Institute, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Y. Y.","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanji","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Kansai Medical University, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien Y.","family":"Wong","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute, Singapore National Eye Centre, Duke-NUS Medical School, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee-Jen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Mackay Memorial Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paisan","family":"Ruamviboonsuk","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Rajavithi Hospital, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin S.","family":"Tan","sequence":"additional","affiliation":[{"name":"National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore"},{"name":"Fundus Image Reading Centre, National Healthcare Group Eye Institute, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Ki","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Seoul St Mary\u2019s Hospital, The Catholic University of Korea, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chui Ming Gemmy","family":"Cheung","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute, Singapore National Eye Centre, Duke-NUS Medical School, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nor Fariza","family":"Ngah","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hospital Shah Alam, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramune","family":"Patalauskaite","sequence":"additional","affiliation":[{"name":"Novartis Ireland Ltd, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Margaron","sequence":"additional","affiliation":[{"name":"Novartis Pharma AG, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Koh","sequence":"additional","affiliation":[{"name":"Eye & Retina Surgeons, Camden Medical Centre, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the EVEREST II Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"eoi200052r1","first-page":"359","article-title":"Polypoidal choroidal vasculopathy: an update on therapeutic approaches.","volume":"8","author":"Wong","year":"2013","journal-title":"J Ophthalmic Vis Res"},{"issue":"1","key":"eoi200052r2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.preteyeres.2009.10.001","article-title":"Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease?","volume":"29","author":"Laude","year":"2010","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"eoi200052r3","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","article-title":"Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management.","volume":"125","author":"Cheung","year":"2018","journal-title":"Ophthalmology"},{"issue":"2","key":"eoi200052r4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000355488","article-title":"Polypoidal choroidal vasculopathy: clinical features and genetic predisposition.","volume":"231","author":"Honda","year":"2014","journal-title":"Ophthalmologica"},{"issue":"9","key":"eoi200052r5","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/bjo.2007.116160","article-title":"Polypoidal choroidal vasculopathy with an appearance similar to classic choroidal neovascularisation on fluorescein angiography.","volume":"91","author":"Iida","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"eoi200052r6","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1097\/IAE.0b013e3182695bf8","article-title":"Polypoidal choroidal vasculopathy\u2014an important diagnosis to make with therapeutic implications.","volume":"32","author":"Kokame","year":"2012","journal-title":"Retina"},{"key":"eoi200052r7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preteyeres.2016.04.002","article-title":"Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians.","volume":"53","author":"Wong","year":"2016","journal-title":"Prog Retin Eye Res"},{"issue":"10","key":"eoi200052r8","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1136\/bjophthalmol-2016-310074","article-title":"Polypoidal choroidal vasculopathy: a common type of neovascular age-related macular degeneration in Caucasians.","volume":"101","author":"Yadav","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"eoi200052r9","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/IAE.0b013e3182852446","article-title":"Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment.","volume":"33","author":"Koh","year":"2013","journal-title":"Retina"},{"issue":"8","key":"eoi200052r10","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","article-title":"EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy.","volume":"32","author":"Koh","year":"2012","journal-title":"Retina"},{"issue":"11","key":"eoi200052r11","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","article-title":"Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial.","volume":"135","author":"Koh","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"eoi200052r12","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1097\/IAE.0000000000000499","article-title":"Three-year results of polypoidal choroidal vasculopathy treated with photodynamic therapy: retrospective study and systematic review.","volume":"35","author":"Wong","year":"2015","journal-title":"Retina"},{"issue":"5","key":"eoi200052r13","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/bjo.2007.135103","article-title":"Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy.","volume":"92","author":"Lai","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"eoi200052r14","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1097\/IAE.0000000000000526","article-title":"Initial versus delayed photodynamic therapy in combination with ranibizumab for treatment of polypoidal choroidal vasculopathy: the Fujisan study.","volume":"35","author":"Gomi","year":"2015","journal-title":"Retina"},{"issue":"5","key":"eoi200052r15","first-page":"1056","article-title":"Ranibizumab alone or in combination with photodynamic therapy vs photodynamic therapy for polypoidal choroidal vasculopathy: a systematic review and meta-analysis.","volume":"8","author":"Tang","year":"2015","journal-title":"Int J Ophthalmol"},{"issue":"10","key":"eoi200052r16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110667","article-title":"Combined intravitreal anti-VEGF and photodynamic therapy versus photodynamic monotherapy for polypoidal choroidal vasculopathy: a systematic review and meta-analysis of comparative studies.","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"20","key":"eoi200052r17","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"eoi200052r18","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/bjophthalmol-2014-305674","article-title":"EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy.","volume":"99","author":"Tan","year":"2015","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"eoi200052r19","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1001\/archopht.117.10.1329","article-title":"Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials\u2014TAP report 1","volume":"117","year":"1999","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"eoi200052r20","first-page":"198","article-title":"Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials\u2014Tap report 2.","volume":"119","author":"Bressler","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"14","key":"eoi200052r21","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration.","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"issue":"11","key":"eoi200052r22","first-page":"1802","article-title":"One-year real-world outcomes of ranibizumab 0.5 mg treatment in Taiwanese patients with polypoidal choroidal vasculopathy: a subgroup analysis of the REAL study.","volume":"11","author":"Chen","year":"2018","journal-title":"Int J Ophthalmol"},{"issue":"7","key":"eoi200052r23","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1001\/jamaophthalmol.2018.1804","article-title":"Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET study: a randomized clinical trial.","volume":"136","author":"Lee","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"eoi200052r24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ajo.2019.02.027","article-title":"Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy: two-year results of the Aflibercept in Polypoidal Choroidal Vasculopathy Study.","volume":"204","author":"Wong","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"eoi200052r25","article-title":"Baseline predictors of visual acuity outcome in patients with wet age-related macular degeneration.","volume":"2018","author":"Zhang","year":"2018","journal-title":"Biomed Res Int"},{"issue":"4","key":"eoi200052r26","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s10384-007-0452-3","article-title":"Role of photodynamic therapy in polypoidal choroidal vasculopathy.","volume":"51","author":"Akaza","year":"2007","journal-title":"Jpn J Ophthalmol"},{"issue":"5","key":"eoi200052r27","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0002-9394(01)00967-9","article-title":"Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization\u2014verteporfin in photodynamic therapy report 2.","volume":"131","author":"Verteporfin In Photodynamic Therapy Study Group","year":"2001","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"eoi200052r28","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s00417-016-3333-y","article-title":"EVEREST study report 3: diagnostic challenges of polypoidal choroidal vasculopathy: lessons learnt from screening failures in the EVEREST study.","volume":"254","author":"Tan","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2768203\/jamaophthalmology_lim_2020_oi_200052_1599662691.64104.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T11:37:41Z","timestamp":1599737861000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2768203"}},"subtitle":["The EVEREST II Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.2443","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,1]]}}}